BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND PAX3, MGC120382, 5077, ENSG00000135903, CDHS, MGC120383, HUP2, P23760, WS1, MGC120384, MGC134778, MGC120381 AND Diagnosis
105 results:

  • 1. Biphenotypic Sinonasal Sarcoma with a Novel PAX7::PPARGC1 Fusion: Expanding the Spectrum of Gene Fusions Beyond the pax3 Gene.
    Bhele S; Chrisinger JSA; Farrell NF; Van Tine BA; Raptis CA; Chernock RD
    Head Neck Pathol; 2023 Sep; 17(3):826-831. PubMed ID: 37378830
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification.
    de Traux de Wardin H; Xu B; Dermawan JK; Smith MH; Wolden SL; Antonescu CR; Wexler LH
    JCO Precis Oncol; 2023 Jun; 7(1):e2200705. PubMed ID: 37315267
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Biphenotypic sinonasal sarcoma-A recently described entity with many mimics: A case report.
    Ingle A; Mahendra N; Gopal Reddy GV
    Indian J Pathol Microbiol; 2023; 66(2):396-399. PubMed ID: 37077095
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Biphenotypic Sinonasal Sarcoma: A Genetically Confirmed Case Showing Bone Invasion Accompanying a Non-neoplastic Respiratory Epithelium.
    Muraoka E; Kato I; Matsumura M; Arai Y; Suenaga J; Yamanaka S; Fujii S
    Int J Surg Pathol; 2023 Oct; 31(7):1414-1419. PubMed ID: 36802923
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Abbou S; Klega K; Tsuji J; Tanhaemami M; Hall D; Barkauskas DA; Krailo MD; Cibulskis C; Nag A; Thorner AR; Pollock S; Imamovic-Tuco A; Shern JF; DuBois SG; Venkatramani R; Hawkins DS; Crompton BD
    J Clin Oncol; 2023 May; 41(13):2382-2393. PubMed ID: 36724417
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. PAX-FOXO1 fusion status in children and adolescents with alveolar rhabdomyosarcoma: Impact on clinical, pathological, and survival features.
    Raze T; Lapouble E; Lacour B; Guissou S; Defachelles AS; Gaspar N; Delattre O; Pierron G; Desandes E
    Pediatr Blood Cancer; 2023 Apr; 70(4):e30228. PubMed ID: 36722003
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Biphenotypic sinonasal sarcoma with pax3/FOXO1 fusion.
    Tosun I; Karabulut MH; Yilmaz I; Cırık AA; Sahin O
    Pol J Pathol; 2023; 74(4):282-285. PubMed ID: 38477090
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Metastatic rhabdomyosarcoma with exclusive distant lymph node involvement: A European Pediatric Soft tissue sarcoma Study Group (EpSSG) report.
    Mercolini F; Merks JHM; Minard-Colin V; Cameron A; van Scheltinga SEJT; Sher O; Fichera G; Orbach D; Glosli H; Coppadoro B; Gallego S; Chisholm JC; Bisogno G
    Pediatr Blood Cancer; 2023 Mar; 70(3):e30143. PubMed ID: 36519598
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Biphenotypic sinonasal sarcoma - a case report.
    Bartoš V; Rác P; Skálová A
    Klin Onkol; 2022; 35(5):402-406. PubMed ID: 36443095
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group.
    Milewski D; Jung H; Brown GT; Liu Y; Somerville B; Lisle C; Ladanyi M; Rudzinski ER; Choo-Wosoba H; Barkauskas DA; Lo T; Hall D; Linardic CM; Wei JS; Chou HC; Skapek SX; Venkatramani R; Bode PK; Steinberg SM; Zaki G; Kuznetsov IB; Hawkins DS; Shern JF; Collins J; Khan J
    Clin Cancer Res; 2023 Jan; 29(2):364-378. PubMed ID: 36346688
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.
    Ruhen O; Lak NSM; Stutterheim J; Danielli SG; Chicard M; Iddir Y; Saint-Charles A; Di Paolo V; Tombolan L; Gatz SA; Aladowicz E; Proszek P; Jamal S; Stankunaite R; Hughes D; Carter P; Izquierdo E; Wasti A; Chisholm JC; George SL; Pace E; Chesler L; Aerts I; Pierron G; Zaidi S; Delattre O; Surdez D; Kelsey A; Hubank M; Bonvini P; Bisogno G; Di Giannatale A; Schleiermacher G; Schäfer BW; Tytgat GAM; Shipley J
    JCO Precis Oncol; 2022 Oct; 6():e2100534. PubMed ID: 36265118
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Biphenotypic Sinonasal Sarcoma with a Novel pax3::FOXO6 Fusion: A Case Report and Review of the Literature.
    Nichols MM; Alruwaii F; Chaaban M; Cheng YW; Griffith CC
    Head Neck Pathol; 2023 Mar; 17(1):259-264. PubMed ID: 36169791
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A rare case of metastatic paraspinal rhabdomyosarcoma presenting with proptosis in an adult patient.
    Chanda UL; Knapp C
    Orbit; 2024 Apr; 43(2):280-282. PubMed ID: 36131600
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.
    Hettmer S; Linardic CM; Kelsey A; Rudzinski ER; Vokuhl C; Selfe J; Ruhen O; Shern JF; Khan J; Kovach AR; Lupo PJ; Gatz SA; Schäfer BW; Volchenboum S; Minard-Colin V; Koscielniak E; Hawkins DS; Bisogno G; Sparber-Sauer M; Venkatramani R; Merks JHM; Shipley J
    Eur J Cancer; 2022 Sep; 172():367-386. PubMed ID: 35839732
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Immunoreactivity against fibroblast growth factor 8 in alveolar rhabdomyosarcoma patients and its involvement in tumor aggressiveness.
    Poli E; Barbon V; Lucchetta S; Cattelan M; Santoro L; Zin A; Milano GM; Zanetti I; Bisogno G; Bonvini P
    Oncoimmunology; 2022; 11(1):2096349. PubMed ID: 35813575
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. High-grade transformation of low-grade biphenotypic sinonasal sarcoma: Radiological, morphophenotypic variation and confirmatory molecular analysis.
    Bell D; Phan J; DeMonte F; Hanna EY
    Ann Diagn Pathol; 2022 Apr; 57():151889. PubMed ID: 35030392
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Primary Cutaneous Alveolar Rhabdomyosarcoma in an Elderly Adult: A Rare Potential Mimic of Merkel Cell Carcinoma.
    Lindsey MS; Bridge JA; Douglas DS; Foster JT; Shalin SC; Gardner JM
    Am J Dermatopathol; 2022 Mar; 44(3):218-222. PubMed ID: 34991098
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Alveolar rhabdomyosarcoma: Two fusion-negative cases lacking pax3-FOXO1 and PAX7-FOXO1].
    Mestre-Alagarda C; Gómez-Mateo MC; Berenguer-Romero MD; Syonghyun NC; Nieto G; Navarro-Fos S
    Rev Esp Patol; 2022; 55(1):57-62. PubMed ID: 34980443
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. pax3-NCOA1 alveolar rhabdomyosarcoma of the tongue: A rare entity with challenging diagnosis and management.
    Di Carlo D; Chargari C; Scoazec JY; Cotteret S; Felix A; Moalla S; Temam S; Minard-Colin V
    Pediatr Blood Cancer; 2021 Nov; 68(11):e29288. PubMed ID: 34424607
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. pax3/7-FOXO1 fusion-negative alveolar rhabdomyosarcoma in Schuurs-Hoeijmakers syndrome.
    Ohkawa T; Nishimura A; Kosaki K; Aoki-Nogami Y; Tomizawa D; Kashimada K; Morio T; Kato M; Mizutani S; Takagi M
    J Hum Genet; 2022 Jan; 67(1):51-54. PubMed ID: 34341476
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.